Zobrazeno 1 - 10
of 104
pro vyhledávání: '"Martin G. Stoel"'
Autor:
Wout W. A. van den Broek, Marieke E. Gimbel, Dean R. P. P. Chan Pin Yin, Jaouad Azzahhafi, Renicus S. Hermanides, Craig Runnett, Robert F. Storey, David Austin, Rohit Oemrawsingh, Justin Cooke, Gavin Galasko, Ronald J. Walhout, Dirk A. A. M. Schellings, Stijn L. Brinckman, Hong Kie The, Martin G. Stoel, Antonius A. C. M. Heestermans, Debby Nicastia, Mireille E. Emans, Arnoud W. J. van ’t Hof, Hannes Alber, Robert Gerber, Paul F. M. M. van Bergen, Ismail Aksoy, Abdul Nasser, Paul Knaapen, Cees-Joost Botman, Anho Liem, Johannes C. Kelder, Jurriën M. ten Berg
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 17, p 5450 (2023)
This registry assessed the impact of conservative and invasive strategies on major adverse clinical events (MACE) in elderly patients with non-ST-elevation myocardial infarction (NSTEMI). Patients aged ≥75 years with NSTEMI were prospectively regis
Externí odkaz:
https://doaj.org/article/3d50129d18b24738929b18b9b0ecb6de
Autor:
Eline H. Ploumen, Tineke H. Pinxterhuis, Rosaly A. Buiten, Paolo Zocca, Peter W. Danse, Carl E. Schotborgh, Martijn Scholte, R. Melvyn Tjon Joe Gin, Samer Somi, K. Gert van Houwelingen, Martin G. Stoel, H. A. F. de Man, Marc Hartmann, Gerard C. M. Linssen, Liefke C. van der Heijden, Marlies M. Kok, Carine J. M. Doggen, Clemens von Birgelen
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 22 (2022)
Background In a previous trial, higher 5‐year mortality was observed following treatment with biodegradable polymer Orsiro sirolimus‐eluting stents (SES). We assessed 5‐year safety and efficacy of all‐comers as well as patients with diabetes
Externí odkaz:
https://doaj.org/article/c65b5fc2cce445438d8fbe4edbda6f2f
Publikováno v:
EJVES Vascular Forum, Vol 52, Iss , Pp 13-16 (2021)
Introduction: Transcatheter aortic valve implantation (TAVI) has evolved into the preferred alternative to surgical valve replacement for severe aortic valve stenosis with high surgical risk. With expanding indications, life threatening complications
Externí odkaz:
https://doaj.org/article/50daca0e29f945c081f1b4decfe64447
Autor:
Liefke C. van der Heijden, Marlies M. Kok, Paolo Zocca, Hanim Sen, Marije M. Löwik, Silvia Mariani, Frits H. A. F. de Man, Marc Hartmann, Martin G. Stoel, K. Gert van Houwelingen, J. (Hans) W. Louwerenburg, Gerard C. M. Linssen, Carine J. M. Doggen, Jan G. Grandjean, Clemens von Birgelen
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 3 (2018)
BackgroundPercutaneous coronary intervention (PCI) in patients with previous coronary artery bypass grafting (CABG) is associated with adverse clinical events. Although newer generation drug‐eluting stents showed favorable short‐term safety profi
Externí odkaz:
https://doaj.org/article/d4b839f1a07e48468123d10dda03d38a
Autor:
Tineke H. Pinxterhuis, Eline H. Ploumen, Paolo Zocca, Carine J.M. Doggen, Carl E. Schotborgh, Rutger L. Anthonio, Ariel Roguin, Peter W. Danse, Edouard Benit, Adel Aminian, Martin G. Stoel, Gerard C.M. Linssen, Robert H. Geelkerken, Clemens von Birgelen
Publikováno v:
International journal of cardiology, 374, 27-32. Elsevier
Background: Both patients with obstructive coronary artery disease (CAD) and patients with peripheral arterial disease (PADs) have an increased bleeding risk. Information is scarce on bleeding in CAD patients, treated with percutaneous coronary inter
Publikováno v:
EJVES Vascular Forum
EJVES Vascular Forum, 52, 13-16. Elsevier
EJVES Vascular Forum, 52, 13-16. Elsevier
Introduction Transcatheter aortic valve implantation (TAVI) has evolved into the preferred alternative to surgical valve replacement for severe aortic valve stenosis with high surgical risk. With expanding indications, life threatening complications
Autor:
Anastasia D Egorova, R R J van Kimmenade, F. van der Kley, Martin G. Stoel, A E Van Den Bosch, Mark G. Hazekamp, Michiel Voskuil, Hubert W. Vliegen, Monique R.M. Jongbloed, P. Damman, R. J. de Winter, Philippine Kiès, R. G. H. Speekenbrink, P. H. Schoof, B. W. Driesen, D. B. H. Verheijen, L. J. Wagenaar, Johan Wouter Jukema, C. J. Koppel, J. Wilschut
Publikováno v:
Netherlands Heart Journal, 29, 311-317
Netherlands Heart Journal, 29(6), 311-317. BOHN STAFLEU VAN LOGHUM BV
Netherlands Heart Journal, 29(6), 311-317. Bohn Stafleu van Loghum
Netherlands heart journal, 29(6), 311-317. Bohn Stafleu van Loghum
Netherlands Heart Journal
Netherlands Heart Journal, 29, 6, pp. 311-317
Netherlands Heart Journal, 29(6), 311-317. BOHN STAFLEU VAN LOGHUM BV
Netherlands Heart Journal, 29(6), 311-317. Bohn Stafleu van Loghum
Netherlands heart journal, 29(6), 311-317. Bohn Stafleu van Loghum
Netherlands Heart Journal
Netherlands Heart Journal, 29, 6, pp. 311-317
Background Current guidelines on coronary anomalies are primarily based on expert consensus and a limited number of trials. A gold standard for diagnosis and a consensus on the treatment strategy in this patient group are lacking, especially for pati
Autor:
Wouter de Ruijter, Iwan C. C. van der Horst, Michael Magro, Niels van Royen, Maarten A. Vink, Bob J.W. Eikemans, Michiel Voskuil, Georgios J. Vlachojannis, José P.S. Henriques, Eric A. Dubois, Martijn Meuwissen, Ton Heestermans, Tom A. Rijpstra, Hans van der Hoeven, Joris J. van der Heijden, Albertus Beishuizen, Pranobe V. Oemrawsingh, Nina W. van der Hoeven, Marcel Gosselink, Gillian A.J. Jessurun, Martin G. Stoel, Pim van der Harst, Gladys N. Janssens, Remon Baak, Hans A. Bosker, Bas van den Bogaard, Peter M. van de Ven, Michiel J. Blans, Harry J.G.M. Crijns, Alexander P.J. Vlaar, Armand R. J. Girbes, Eva M. Spoormans, Gabe B. Bleeker, Koos Plomp, Jorrit S. Lemkes, Lucia S.D. Jewbali, Paul W. G. Elbers, Thijs Delnoij, Cyril Camaro
Publikováno v:
Critical Care Medicine, 50(2), E129-E142. Lippincott Williams and Wilkins
Critical Care Medicine, 50, 2, pp. E129-E142
Critical care medicine, 50(2), e129-e142. Lippincott Williams and Wilkins
Critical Care Medicine, 50(2), e129-e142. LIPPINCOTT WILLIAMS & WILKINS
Critical Care Medicine, 50(2), E129-E142. Lippincott Williams & Wilkins
Spoormans, E M, Lemkes, J S, Janssens, G N, van der Hoeven, N W, Jewbali, L S D, Dubois, E A, Meuwissen, M, Rijpstra, T A, Bosker, H A, Blans, M J, Bleeker, G B, Baak, R, Vlachojannis, G J, Eikemans, B J W, Girbes, A R J, van der Harst, P, van der Horst, I C C, Voskuil, M, van der Heijden, J J, Beishuizen, A, Stoel, M, Camaro, C, van der Hoeven, H, Henriques, J P, Vlaar, A P J, Vink, M A, van den Bogaard, B & Heestermans, T A C M 2022, ' Targeted Temperature Management in Out-of-Hospital Cardiac Arrest With Shockable Rhythm : A Post Hoc Analysis of the Coronary Angiography After Cardiac Arrest Trial ', Critical Care Medicine, vol. 50, no. 2, pp. E129-E142 . https://doi.org/10.1097/CCM.0000000000005271
Critical Care Medicine, 50, E129-E142
Critical Care Medicine, 50(2), E129-E142. LIPPINCOTT WILLIAMS & WILKINS
Critical Care Medicine, 50, 2, pp. E129-E142
Critical care medicine, 50(2), e129-e142. Lippincott Williams and Wilkins
Critical Care Medicine, 50(2), e129-e142. LIPPINCOTT WILLIAMS & WILKINS
Critical Care Medicine, 50(2), E129-E142. Lippincott Williams & Wilkins
Spoormans, E M, Lemkes, J S, Janssens, G N, van der Hoeven, N W, Jewbali, L S D, Dubois, E A, Meuwissen, M, Rijpstra, T A, Bosker, H A, Blans, M J, Bleeker, G B, Baak, R, Vlachojannis, G J, Eikemans, B J W, Girbes, A R J, van der Harst, P, van der Horst, I C C, Voskuil, M, van der Heijden, J J, Beishuizen, A, Stoel, M, Camaro, C, van der Hoeven, H, Henriques, J P, Vlaar, A P J, Vink, M A, van den Bogaard, B & Heestermans, T A C M 2022, ' Targeted Temperature Management in Out-of-Hospital Cardiac Arrest With Shockable Rhythm : A Post Hoc Analysis of the Coronary Angiography After Cardiac Arrest Trial ', Critical Care Medicine, vol. 50, no. 2, pp. E129-E142 . https://doi.org/10.1097/CCM.0000000000005271
Critical Care Medicine, 50, E129-E142
Critical Care Medicine, 50(2), E129-E142. LIPPINCOTT WILLIAMS & WILKINS
OBJECTIVES: The optimal targeted temperature in patients with shockable rhythm is unclear, and current guidelines recommend targeted temperature management with a correspondingly wide range between 32°C and 36°C. Our aim was to study survival and n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b33b109d1be2c0baa3afe361318b94b0
https://research.vumc.nl/en/publications/07fc516d-9dca-42b5-be9b-f8c4ae5a9d0d
https://research.vumc.nl/en/publications/07fc516d-9dca-42b5-be9b-f8c4ae5a9d0d
Autor:
Eline H. Ploumen, Clemens von Birgelen, Marlies M. Kok, Paolo Zocca, Rosaly A. Buiten, Marc Hartmann, Frits H.A.F. de Man, Martin G. Stoel, Gerard C.M. Linssen, Cees Doelman, Gert D. Kant, K. Gert van Houwelingen, Carine J.M. Doggen
Publikováno v:
Catheterization and cardiovascular interventions, 96(2), E110-E118. Wiley-Liss Inc.
Catheterization and Cardiovascular Interventions
Catheterization and Cardiovascular Interventions
Background Patients with coronary disease may have unknown diabetes or prediabetes. We evaluated 3‐year outcomes after percutaneous coronary intervention (PCI) with contemporary drug‐eluting stents (DES) in patients with silent diabetes, prediabe
Autor:
Paolo Zocca, Edouard Benit, Marc Hartmann, Samer Somi, Eline H. Ploumen, K. Gert van Houwelingen, Carl E. Schotborgh, Ariel Roguin, Carine J.M. Doggen, Peter W. Danse, Rosaly A. Buiten, Alexander R. Schramm, Martin G. Stoel, Gerard C.M. Linssen, Clemens von Birgelen, Adel Aminian, Gillian A.J. Jessurun
Publikováno v:
JACC: Cardiovascular Interventions, 13(9), 1100-1109. Elsevier
Objectives The aim of this study was to assess 2-year safety and efficacy of the current-generation thin composite-wire-strut durable-polymer Resolute Onyx zotarolimus-eluting stent (ZES), compared with the ultrathin-strut biodegradable-polymer Orsir